000830:SZSELuxi Chemical Group Co., Ltd. Analysis
Data as of 2026-03-17 - not real-time
CN¥17.22
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading at 17.22 CNY, just above the computed support of 17.11 CNY and well below the 52‑week high of 21.8 CNY. Despite the price sitting under the 20‑day (18.82) and 50‑day (18.32) SMAs, the 200‑day SMA (14.27) remains comfortably lower, signaling a longer‑term bullish bias. Momentum indicators are mixed – RSI sits at 41.6, suggesting neutral pressure, while the MACD histogram is negative, hinting at short‑term bearishness. Volume is on an increasing trend, and the market sentiment index reads “Extreme Greed,” implying strong buyer enthusiasm. Volatility is elevated at nearly 70% over the past 30 days, yet the computed beta is almost zero, indicating low systematic market risk.
Fundamental backdrop: Revenue has contracted by roughly 5% year‑over‑year, and margins are modest (gross ~12%, operating ~11%). The company carries a debt‑to‑equity ratio of about 62%, with cash reserves covering only a fraction of total debt, which raises leverage concerns. Valuation metrics sit near the market median – forward P/E around 16.7, price‑to‑book 1.72, and price‑to‑sales 1.09 – while the dividend yield of 2.0% and a payout ratio under 50% suggest a reasonably sustainable payout. Analyst consensus is a “strong buy” with a target price near 18.5 CNY, implying upside of roughly 7‑8% from current levels.
Fundamental backdrop: Revenue has contracted by roughly 5% year‑over‑year, and margins are modest (gross ~12%, operating ~11%). The company carries a debt‑to‑equity ratio of about 62%, with cash reserves covering only a fraction of total debt, which raises leverage concerns. Valuation metrics sit near the market median – forward P/E around 16.7, price‑to‑book 1.72, and price‑to‑sales 1.09 – while the dividend yield of 2.0% and a payout ratio under 50% suggest a reasonably sustainable payout. Analyst consensus is a “strong buy” with a target price near 18.5 CNY, implying upside of roughly 7‑8% from current levels.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Mixed momentum signals (neutral RSI, bearish MACD)
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst upside potential of ~7‑8%
- Attractive dividend yield with sustainable payout
- Fair valuation relative to peers
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Elevated leverage and declining revenue trend
- Cyclical nature of specialty chemicals sector
- Stable dividend and moderate long‑term growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth-4.80%
Profit Margin4.91%
P/E Ratio22.4
ROE7.88%
ROA3.58%
Debt/Equity62.01
P/B Ratio1.7
Op. Cash FlowCN¥4.4B
Free Cash FlowCN¥100.0M
Technical Analysis
TrendBullish
RSI41.6
SupportCN¥17.11
ResistanceCN¥21.80
MA 20CN¥18.82
MA 50CN¥18.32
MA 200CN¥14.27
MACDBearish
VolumeIncreasing
Fear & Greed Index81.48
Valuation
Target PriceCN¥18.53
Upside/Downside7.63%
GradeFair
TypeBlend
Dividend Yield2.03%
Risk Assessment
Beta0.01
Volatility69.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.